Generic Name: esterified estrogens and methyltestosterone (Oral route)
es-TER-i-fide ES-troe-jenz, meth-il-tes-TOS-ter-one
Estrogens increase the risk of endometrial cancer; monitor for abnormal vaginal bleeding. Estrogens with or without progestins should not be used for the prevention of cardiovascular disease or dementia. Increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years) have been reported. An increased risk of developing probable dementia in postmenopausal women 65 years or older has also been reported. This product contains an estrogen and androgen, not a progestin. This combination should not be used during a known or suspected pregnancy .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Estrogen/Androgen Combination
Pharmacologic Class: Estrogen
